DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 1 USDMF, 4 Listed Suppliers, $ API Reference Price

5 API Suppliers
1 USDMF
4 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 Listed Dossiers

1 FDF Dossiers
1 Listed Dossiers

MARKET PLACE

4 APIs

marketPlace
4 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 24

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Meglumine antimonate, Meglumine antimoniate, N-methylglucamine antimonate, 133-51-7, Methylglucamine antimonate, Protostib

Molecular Formula

C₇H₁₈NO₈Sb

Molecular Weight

365.98 g/mol

InChI Key

XOGYVDXPYVPAAQ-SESJOKTNSA-M

FDA UNII

75G4TW236W

ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS.

1 2D Structure

Meglumine Antimonate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

hydroxy(dioxo)-5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol

2.1.2 InChI

InChI=1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1

2.1.3 InChI Key

XOGYVDXPYVPAAQ-SESJOKTNSA-M

2.1.4 Canonical SMILES

CNCC(C(C(C(CO)O)O)O)O.O[Sb](=O)=O

2.1.5 Isomeric SMILES

CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.O[Sb](=O)=O

2.2 Other Identifiers

2.2.1 UNII

75G4TW236W

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Meglumine Antimoniate

2. N Methylglucamine Antimonate

3. N-methylglucamine Antimonate

2.3.2 Depositor-Supplied Synonyms

1. Meglumine Antimonate

2. Meglumine Antimoniate

3. N-methylglucamine Antimonate

4. 133-51-7

5. Methylglucamine Antimonate

6. Protostib

7. 75g4tw236w

8. N-methyl Glucamine Antimoniate

9. 2168-rp

10. Einecs 205-108-3

11. Glucantim

12. Unii-75g4tw236w

13. 1-deoxy-1-(methylamino)glucitol Antimonate(v)

14. 1-deoxy-1-(methylamino)-d-glucitol, Compound With Antimonic Acid (1:1)

15. D-glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (1:1)

16. Glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (1:1), D-

17. Schembl146372

18. Dtxsid4043935

19. D-glucitol, 1-deoxy-1-(methylamino)-, Trioxoantimonate(1-)

20. Mfcd01725422

21. Meglumine Antimonate [who-dd]

22. Akos025310684

23. Db13732

24. N-methylglucamine Antimonate [mi]

25. 133m517

26. Q2757969

27. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol Stibenate

28. D-glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (hsbo3) (1:1)

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₇H₁₈NO₈Sb
Molecular Weight	365.98 g/mol
Hydrogen Bond Donor Count	7
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	6
Exact Mass	365.00705 g/mol
Monoisotopic Mass	365.00705 g/mol
Topological Polar Surface Area	168 Å²
Heavy Atom Count	17
Formal Charge	0
Complexity	180
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2